Syngene International enters into partnership with Zumutor Biologics

30 May 2018 Evaluate

Syngene International has entered into a non-exclusive partnering agreement with Zumutor Biologics, an emerging immuno-oncology company, to access Zumutor’s proprietary naive human phage/yeast display library. This collaboration further enhances Syngene’s market-leading capabilities in Discovery Biology, providing its scientists with additional tools to help solve complex biology problems in biotherapeutic drug discovery.

Under the terms of the agreement, Syngene will screen target antigens against Zumutor’s proprietary human antibody libraries to identify and characterize novel antibody clones, which will be further developed by Syngene towards novel biotherapeutics programs for its partners.

Syngene International is India’s largest Contract Research Services Organization providing integrated discovery and development services for novel molecules across multiple platforms including small molecules, large molecules, Antibody-Drug Conjugates and Oligonucleotides.


Syngene Internation. Share Price

659.95 13.60 (2.10%)
15-Dec-2025 14:59 View Price Chart
Peers
Company Name CMP
Syngene Internation. 659.95
Indegene 527.05
CMS Info Systems 347.85
Sagility 51.10
Smartworks Coworking 475.80
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×